Pfizer, Merck Lead Strata Oncology’s $26M Series B Round

Pfizer, Merck Lead Strata Oncology’s $26M Series B Round

Submitted by admin on May 25, 2018 - 9:23am
Source: 
Xconomy
News Tags: 
Strata Oncology
Pfizer Venture Investments
Merck Global Health Innovation
Headline: 
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
snippet: 
In what company leaders describe as a “huge step,” Ann Arbor, MI-based precision medicine startup Strata Oncology this week closed a $26 million Series B investment round led by Pfizer Ventures and the Merck Global Health Innovation Fund.

Do Not Allow Advertisers to Use My Personal information